Protocol for a double-blind placebocontrolled randomised controlled trial assessing the impact of oral semaglutide in amyloid positivity (ISAP) in community dwelling UK adults

Ivan Koychev*, Amanda I Adler, Paul Edison, Brian D. Tom, Joanne E Milton, Joe Butchart, Adam Hampshire, Charles Marshall, E J Coulthard, Henrik Zetterberg, Peter Hellyer, Francesca K Cormack, Benjamin R Underwood, Catherine J Mummery, Rury R. Holman

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

Fingerprint

Dive into the research topics of 'Protocol for a double-blind placebocontrolled randomised controlled trial assessing the impact of oral semaglutide in amyloid positivity (ISAP) in community dwelling UK adults'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry